首页> 外文期刊>Journal of drug delivery science and technology >Intercalation of shRNA-plasmid in Mg-Al layered double hydroxide nanoparticles and its cellular internalization for possible treatment of neurodegenerative diseases
【24h】

Intercalation of shRNA-plasmid in Mg-Al layered double hydroxide nanoparticles and its cellular internalization for possible treatment of neurodegenerative diseases

机译:Mg-Al层层双氢氧化物纳米粒子中ShRNA-质粒的嵌入及其对神经变性疾病的可能治疗的细胞内化

获取原文
获取原文并翻译 | 示例
           

摘要

In the present work, nanoconjugates of shRNA-plasmid and a non-viral nanoceramic vector, e.g., Mg-Al layered double hydroxide (Mg-Al LDH), were synthesized and intercalated. Subsequently, these particles with an average size of 40-60 nm, were transfected into mammalian neuroblastoma cells (SH-SY5Y). The as prepared Mg-Al LDH was able to protect the incorporated shRNA-plasmid against a range of pH values, DNasel, endonucleases, and serum components. To test the applicability of the nanoconjugate for future in-vivo studies, serum from three different model experimental animals viz, mouse, rat and guinea pig was used for the serum protection study. Additionally, we showed that prolonged storage at different temperatures does not affect the quality of the nanoconjugate. Using this nanoconjugate to transform cells, a maximum internalization of ~ 26% at 24h was achieved. Lastly, we demonstrated effective and safe delivery of the plasmid by measuring GFP production and shRNA-induced knockdown of TNF alpha.
机译:在本作本作中,合成和插入ShRNA-质粒的纳米缀合物和非病毒纳米陶瓷载体,例如Mg-Al层叠双氢氧化物(Mg-Al LDH)。随后,将具有平均尺寸为40-60nm的这些颗粒转染到哺乳动物神经母细胞瘤细胞(SH-SY5Y)中。如制备的Mg-Al LDH能够保护掺入的掺入的ShRNA质粒免受一系列pH值,DNASEL,内切核酸酶和血清组分。为了测试纳米缀合物的适用性未来体内研究,血清来自三种不同模型实验动物的血清,小鼠,大鼠和豚鼠用于血清保护研究。此外,我们表明,不同温度的长时间储存​​不会影响纳米缀合物的质量。使用该纳米缀合物转化细胞,实现了26小时的最大内化〜26%。最后,我们通过测量GFP生产和ShRNA诱导的TNFα敲低来证明了质粒的有效和安全的递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号